What Happens When Opioid Use Disorder Goes Untreated: A Guide for Middlesex County Families

Untreated opioid use disorder does not plateau. Without intervention, the physical, neurological, and psychiatric consequences compound over time in ways that become increasingly difficult to reverse.

That is the answer to the question most families are actually asking when they ask whether to push the issue: no, this does not level off on its own, and waiting is not a neutral choice. What follows is what untreated opioid dependence does to the brain and the body, in the order it tends to happen — including the one phase that is far more dangerous than most families expect, and that arrives after a stretch of not using.

How Opioid Use Disorder Progresses Without Treatment

Heroin and other opioids bind to mu-opioid receptors in the brain, triggering a flood of dopamine that the brain rapidly learns to depend on. Over time, the brain reduces its own production of dopamine and downregulates receptor sensitivity — meaning the person needs more of the drug to feel normal, not just to feel high.

This neurological shift is not a character flaw or a failure of willpower. It is a documented physiological change. The brain's reward system, decision-making centers, and stress-regulation pathways are all structurally altered by prolonged opioid exposure.

Without treatment, several things happen in sequence:

Tolerance escalates. Doses that once produced euphoria now prevent withdrawal symptoms. The person is no longer using to feel good — they are using to avoid feeling sick. This distinction matters because it changes the calculus of quitting: stopping abruptly raises the risk of relapse and overdose, because tolerance drops.

Physical dependence deepens. Opioid withdrawal produces symptoms including severe muscle cramping, vomiting, diarrhea, insomnia, cold sweats, and intense anxiety. While rarely fatal on its own, withdrawal is profoundly uncomfortable and drives relapse in the absence of medical support. Many people return to use not because they want to, but because the physical experience of stopping is intolerable without help.

Behavior reorganizes around use. As the disease progresses, daily functioning — work, relationships, finances, healthcare — deteriorates. This is not a slow slide; for many people it accelerates as tolerance rises and the cost of maintaining use increases.

Overdose risk grows. Tolerance is not stable. After any period of abstinence — even a few days — tolerance drops sharply. If someone relapses after a break and uses the same dose they used before stopping, their risk of fatal overdose is significantly elevated. This is one of the most dangerous phases of untreated opioid use disorder, and it is common.

The Overdose Risk Is Not Hypothetical

That last point deserves its own section, because it runs against intuition. The most dangerous moment is often not the deepest part of use. It is the return to use after a few clean days — a jail stay, a hospital admission, a weekend of trying to stop — when the body's tolerance has fallen and the habitual dose has not.

Fentanyl has changed the overdose landscape in New Jersey in ways that make untreated opioid use disorder more acutely dangerous than it was a decade ago. In New Jersey, most overdose deaths involve fentanyl, and more than 90% of drugs seized by police in 2023–2025 tested positive for it (NJ State Commission of Investigation, 2025).

Fentanyl is roughly 50 to 100 times more potent than morphine. As little as 2 milligrams, about the size of a few grains of salt, can be fatal. There is no way to detect fentanyl by sight, smell, or taste.

Naloxone (Narcan) reverses opioid overdose and is available without a prescription at pharmacies throughout Middlesex County. It is a critical harm reduction tool for families of individuals with untreated opioid use disorder. Having naloxone on hand does not enable addiction — it prevents a preventable death while the longer-term work of treatment continues.

If you suspect an overdose, call 911 first or right after the first dose, give another dose every 2 to 3 minutes if the person does not wake, and stay until help arrives. Naloxone does not reverse xylazine or medetomidine, so call 911 even if the person starts breathing.

But naloxone is not a substitute for treatment. It reverses an overdose in the moment; it does not address the disorder that produced the overdose.

The Mental Health Connection: Co-Occurring Disorders

Opioid use disorder and mental health conditions rarely travel alone. Among U.S. adults aged 18–64 with OUD in 2015–2017, 64.3% had a past-year mental illness and 26.9% serious mental illness (NSDUH; Jones and McCance-Katz, 2019).

The relationship runs in both directions. Some people begin using opioids as an attempt to manage untreated mental health symptoms — pain, hyperarousal, insomnia, emotional numbness. Others develop depression or anxiety as a direct consequence of the neurological changes that opioid dependence produces. In both cases, guidelines recommend addressing both conditions rather than treating one and ignoring the other.

Depression. Opioids artificially suppress the brain's stress response. When use stops, or even between doses as tolerance rises, the brain overcorrects — producing a baseline state of dysphoria, hopelessness, and anhedonia. Without treatment, this depressive state drives continued use and significantly elevates suicide risk.

Anxiety and PTSD. Many individuals with opioid use disorder have trauma histories. PTSD and opioid dependence interact in ways that reinforce each other: hyperarousal drives use, withdrawal amplifies hyperarousal, and avoidance of withdrawal keeps the person locked in the cycle. Treating opioid dependence without addressing underlying trauma leaves the primary driver of use unaddressed.

Cognitive impairment. Prolonged opioid use affects executive function, memory, and impulse control. These effects are often partially reversible with sustained abstinence and treatment, but they worsen with continued, untreated use. For Middlesex County residents trying to manage work, family, and finances alongside addiction, cognitive impairment creates cascading consequences.

For families watching this unfold, it is worth knowing: what looks like laziness, dishonesty, or selfishness is frequently the behavioral expression of altered brain chemistry. That does not remove accountability, but it does mean that shame and pressure alone are not treatment.

What Untreated Opioid Use Disorder Does to Families

The consequences of untreated opioid use disorder extend outward. Families in Middlesex County navigating a loved one's addiction commonly experience:

• Financial strain from theft, job loss, or supporting an adult child unable to maintain employment
• Secondary trauma from crisis events, overdoses, arrests, or hospitalizations
• Enabling patterns that develop as survival strategies — paying bills, making excuses, absorbing consequences — that unintentionally extend the time before treatment occurs
• Erosion of trust that complicates family relationships long after the person enters recovery

Family members benefit from their own support resources. Al-Anon and Nar-Anon have meetings in the Middlesex County area. The Middlesex County Behavioral Health Navigators (732-745-3810) can provide guidance for families as well as individuals.

Understanding the disease model of addiction — that opioid use disorder is a chronic, relapsing brain disease with an established evidence base for treatment — changes how families can engage. It does not mean accepting harmful behavior without limits. It means knowing that outcomes are substantially better with treatment than without, and that waiting for someone to hit bottom is not a clinical strategy.

Levels of Care for Opioid Use Disorder in New Jersey

New Jersey has a tiered system of care for opioid use disorder. The appropriate level depends on the severity of dependence, co-occurring psychiatric conditions, social support, and prior treatment history.

Medical detoxification. Many people start buprenorphine or methadone directly, in an office, clinic, or treatment program, without a separate detox stay. Medically supervised withdrawal management helps when someone has other medical or psychiatric risks, and it should lead straight into ongoing medication treatment.

Medication-assisted treatment (MAT). Buprenorphine (Suboxone) and methadone are FDA-approved medications that reduce cravings, prevent withdrawal, and significantly lower overdose risk. MAT is not substituting one addiction for another — it is evidence-based pharmacological treatment for a medical condition. New Jersey has expanded access to buprenorphine through primary care and outpatient settings, including providers serving South Brunswick and Middlesex County.

Residential and inpatient treatment. For individuals with severe dependence, co-occurring psychiatric conditions, or unstable home environments, residential treatment provides 24-hour structure; whether mental health care is integrated, and how much medical staffing is on site, varies by program, so ask. The New Jersey Department of Health licenses residential treatment programs; DMHAS funds state-supported placements.

Intensive outpatient and partial hospitalization. These levels of care provide structured programming — IOP typically 9 to 19 hours a week; PHP 20 or more — while allowing the person to live at home or in a recovery residence. They are appropriate for individuals who have stabilized medically but need more support than standard outpatient.

Ongoing outpatient care. Long-term outpatient treatment, often combined with MAT, supports sustained recovery. Co-occurring mental health conditions are addressed through individual therapy, psychiatric medication management, and group support.

The Numbers to Have Before You Need Them

Two of these are worth saving to a phone now rather than looking up during an emergency.

911 — Call 911 for a suspected overdose, or if someone is unresponsive, having a seizure, or struggling to breathe.

988 Suicide and Crisis Lifeline — Call or text 988. Available 24/7 for mental health and substance use crises. Trained counselors can connect callers to local resources.

ReachNJ — Call 1-844-732-2465. New Jersey's addiction helpline, available 24/7 regardless of insurance status.

Middlesex County Behavioral Health Navigators — Call 732-745-3810. Navigators offer free, confidential help finding mental health and substance use services.

NJMentalHealthCares — Call 866-202-4357. A statewide behavioral health information and referral line (daily, 8am–8pm) staffed by trained specialists who can identify providers and support families.

The one thing a family can do this week, before any decision about treatment is settled, is get naloxone into the house and make sure more than one person knows how to use it. It does not commit anyone to anything, and it covers the window in which the wrong day becomes irreversible. If it is ever used, call 911 as well, even if the person wakes up.